Hill M, Hillova J, Brada Z, Mariage-Samson R
Laboratory of Cellular and Molecular Biology, I.C.I.G., Hôpital Paul-Brousse, Villejuif, France.
Anticancer Res. 1987 Nov-Dec;7(6):1245-50.
Methionine has been successfully used to control tumor progression in vivo and to induce reversions of transformed cells in vitro. In the present study, we measured mutations at the HGPRT locus of RSV-transformed cells serially propagated in methionine-supplemented medium and assayed at each passage for thioguanine resistance. The frequency of spontaneous mutants at this locus was 7.2 X 10(-5); this value gradually increased during the methionine treatment to as much as 9.2 X 10(-4), and returned to initial values when the methionine treatment was withdrawn. It is proposed that the mutants were induced by the methionine derivative, S-adenosylmethionine, and the resulting mutant frequency determined by equilibrium between mutagenic action of this metabolite and DNA repair.
甲硫氨酸已成功用于体内控制肿瘤进展以及体外诱导转化细胞的逆转。在本研究中,我们检测了在补充甲硫氨酸的培养基中连续传代培养的劳氏肉瘤病毒(RSV)转化细胞的次黄嘌呤-鸟嘌呤磷酸核糖转移酶(HGPRT)位点的突变情况,并在每一代传代时检测对硫鸟嘌呤的抗性。该位点自发突变体的频率为7.2×10⁻⁵;在甲硫氨酸处理期间,这个值逐渐增加至高达9.2×10⁻⁴,当撤去甲硫氨酸处理时又恢复到初始值。有人提出,这些突变体是由甲硫氨酸衍生物S-腺苷甲硫氨酸诱导产生的,而最终的突变频率由这种代谢产物的诱变作用与DNA修复之间的平衡所决定。